Variant Investments, an alternative credit investment manager with nearly $3 billion in assets under management, today published its 2025 Annual Impact Report for the Variant Impact Fund (IMPCX), ...

The FDA has approved a new treatment, sold under the name Anzupgo and containing a drug called delgocitinib, as the first skin cream for adults with long-term or chronic hand eczema (CHE), which ...